Home > Insider Trading > Filing (0001209191-14-052614)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
938296	H Theodore Stanley	C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-13	2,000	$33.86	3,000	No	4	P	Indirect	by non-profit corporation
Common Stock	Acquisiton	2014-08-13	1,000	$34.08	5,100	No	4	P	Indirect	by limited partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by non-profit corporation
No	4	P	Indirect	by limited partnership

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,000	Direct

Footnotes

Reflects a reduction in direct holdings by 5,100 shares which were errenously reported as directly held in prior Form 4 filings.
Includes 1,000 shares errenously reported as directly held in prior Form 4 filings. The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein.
Includes 4,100 shares errenously reported as directly held in prior Form 4 filings. The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein.